Serge Saxonov - 22 Feb 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
22 Feb 2023
Net transactions value
-$92,689
Form type
4
Filing time
24 Feb 2023, 16:51:14 UTC
Previous filing
14 Dec 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $92,689 -1,941 -0.21% $47.75 909,715 22 Feb 2023 Direct F1
holding TXG Class A Common Stock 747 22 Feb 2023 See footnote F2
holding TXG Class A Common Stock 145,960 22 Feb 2023 See footnote F3
holding TXG Class A Common Stock 870 22 Feb 2023 See footnote F4
holding TXG Class A Common Stock 9,400 22 Feb 2023 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.